Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_3
2
17%
Ph not_applicable
6
50%
Ph phase_2
1
8%
Ph phase_4
2
17%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
6(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(10)
Other(1)

Detailed Status

Completed10
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 32 (16.7%)
Phase 42 (16.7%)
N/A6 (50.0%)

Trials by Status

unknown18%
active_not_recruiting18%
completed1083%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12